# FDA recall D-0816-2018

> **L. Perrigo Company** · Class II · drug recall initiated 2018-05-11.

## Product

Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010

## Reason for recall

Defective delivery system

## Distribution

Nationwide in the U.S.A.

## Key facts

- **Recall number:** D-0816-2018
- **Recalling firm:** L. Perrigo Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-05-11
- **Report date:** 2018-05-23
- **Termination date:** 2020-09-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Allegan, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0816-2018

## Citation

> AI Analytics. FDA recall D-0816-2018. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0816-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*